Healthcare
January 24, 2018 / 3:15 AM / a year ago

BRIEF-Shanghai Fosun Pharmaceutical Group units receive approval for drug clinical trials

1 Min Read

Jan 24 (Reuters) - Shanghai Fosun Pharmaceutical Group Co Ltd

* Says two pharmaceutical units received drug clinical trials approval for capsule FCN-437c and crude drug, which will be mainly used for treatment of solid tumor

Source text in Chinese:goo.gl/KA8dec

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below